Accelerate groundbreaking research
We all hope and dream to live long, healthy lives. But severe chronic lung diseases such as COPD and asthma threaten this dream for 500 million people. Already, COPD is the third cause of death worldwide. One day, researchers will find cures and preventive treatments. Crucial solutions that can and will become available much sooner when we join forces internationally. LONGFONDS | Accelerate has made this possible. Join us today.
Updates
-
New research consortium focuses on promising asthma medication
/sites/default/files/styles/news_overview/public/2024-05/BenMarsland_1400x800.png?itok=smbaWOuyThanks to the award of a Public Private Partnership subsidy, Longfonds can support the close collaboration between scientists and the newly launched start-up, Atopius Health.
> Read more -
Mini-organs offer insights into congenital conditions
/sites/default/files/styles/news_overview/public/2024-03/Longorganoide_accelerate_1400x800.png?itok=LAD79i6mScientists have succeeded in cultivating stem cells from late-stage pregnancy into mini-organs.
> Read more
Research projects
LONGFONDS | Accelerate focuses on asthma prevention and lung regeneration. Find out more about the groundbreaking research and the great promise.
Impact
Chronic lung disease causes 10.000 deaths each day
worldwide
500 million people suffer from chronic lung disease
worldwide
2.800 children hospitalized with breathing difficulties each year
in the Netherlands
Partners
Intro